PLA2R Immunohistochemistry Staining in Membranous Glomerulopathy: A Challenging Stain to Interpret But a Potentially Useful Diagnostic Tool
暂无分享,去创建一个
A. Sidoni | Martina Mandarano | G. Bellezza | C. Covarelli | R. Del Sordo | R. Brugnano | Raffaela Sciri | M. Mandarano
[1] Chong Zhang,et al. Clinicopathological features in membranous nephropathy with cancer: A retrospective single-center study and literature review , 2019, The International journal of biological markers.
[2] Baoli Liu,et al. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role , 2019, Front. Immunol..
[3] Yuliang Zhao,et al. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis , 2019, International Urology and Nephrology.
[4] R. Stahl,et al. Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome , 2019, Modern Pathology.
[5] F. Pieruzzi,et al. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain , 2018, Journal of Nephrology.
[6] Kyung-Hee Kim,et al. The Usefulness of Phospholipase A2 Receptor and IgG4 Detection in Differentiation Primary Membranous Nephropathy From Secondary Membranous Nephropathy in Renal Biopsy , 2017, Applied immunohistochemistry & molecular morphology : AIMM.
[7] M. Uppin,et al. Immunohistochemical Analysis of Anti-phospholipase A2 Receptor Antibody on Renal Biopsies: A Single Tertiary Care Center Study , 2017, Indian journal of nephrology.
[8] S. Varughese,et al. Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations , 2017, Nephron Extra.
[9] W. Luo,et al. Detection and clinical significance of glomerular M‐type phospholipase A2 receptor in patients with idiopathic membranous nephropathy , 2016, Internal medicine journal.
[10] Hong Cheng,et al. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy , 2016, PloS one.
[11] B. Haraldsson,et al. Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy , 2015, Clinical kidney journal.
[12] M. Haas,et al. Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods. , 2015, Clinical nephrology.
[13] Xiaoye Zhu,et al. Renal Phospholipase A2 Receptor in Hepatitis B Virus-Associated Membranous Nephropathy , 2015, American Journal of Nephrology.
[14] T. Itoh,et al. Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype , 2015, Virchows Archiv.
[15] H. Debiec,et al. Anti-Phospholipase A2 Receptor Antibodies and the Pathogenesis of Membranous Nephropathy , 2014, Nephron Clinical Practice.
[16] Nora Hornig,et al. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1. , 2014, Autoimmunity reviews.
[17] N. Valtierra,et al. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[18] V. Tesar,et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] U. Panzer,et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.
[20] 克治 桑門. 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .
[21] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.